# Wave Life Sciences, Inc.: filings

WVE · Nasdaq · CIK 1631574 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/wve.md) · [Financials](/companies/wve/financials.md) · [Filings](/companies/wve/filings.md) · [Insiders](/companies/wve/insiders.md)

## Reports and events: 260 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 244, 8-K 156, SC 13G/A 37, 10-Q 34, 144 31, 3 24, SC 13G 18, S-8 16, S-8 POS 16, SC 13D/A 15, 10-K/A 13, 424B5 13, DEF 14A 12, 10-K 11, UPLOAD 9, CORRESP 8, EFFECT 6, SCHEDULE 13G/A 6, 8-K/A 5, S-1/A 5, SCHEDULE 13D/A 5, CT ORDER 4, ARS 3, S-3 3, SC 13D 3, D 2, DEFA14A 2, DRS/A 2, POS AM 2, POSASR 2, S-3ASR 2, 15-12G 1, 424B1 1, 424B2 1, 424B3 1, 4/A 1, 5 1, 8-A12B 1, 8-K12B 1, CERTNAS 1, DRS 1, DRSLTR 1, PRE 14A 1, PRER14A 1, S-1 1, S-1MEF 1, S-3/A 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-27 | 07:50 ET | [10-Q](/filings/0001193125-26-432714.md) | Quarterly report, period 2026-09-30 | 0001193125-26-432714 |
| 2026-10-27 | 07:35 ET | [8-K](/filings/0001193125-26-432690.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-432690 |
| 2026-10-14 | 17:14 ET | [DEF 14A](/filings/0001193125-26-421806.md) | Proxy statement, period 2026-11-12 | 0001193125-26-421806 |
| 2026-08-11 | 16:39 ET | [SCHEDULE 13D/A](/filings/0001346824-26-000222.md) | Ownership report, active investor, amended | 0001346824-26-000222 |
| 2026-07-30 | 07:50 ET | [10-Q](/filings/0001193125-26-324949.md) | Quarterly report, period 2026-06-30 | 0001193125-26-324949 |
| 2026-07-30 | 07:38 ET | [8-K](/filings/0001193125-26-324917.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-324917 |
| 2026-06-26 | 08:30 ET | [8-K](/filings/0001193125-26-284002.md) | 5.07 Shareholder vote results | 0001193125-26-284002 |
| 2026-05-18 | 16:51 ET | [8-K](/filings/0001193125-26-229076.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-229076 |
| 2026-05-07 | 16:01 ET | [DEF 14A](/filings/0001193125-26-211828.md) | Proxy statement, period 2026-06-22 | 0001193125-26-211828 |
| 2026-04-30 | 16:15 ET | [10-K/A](/filings/0001193125-26-197330.md) | Annual report, amended, period 2025-12-31 | 0001193125-26-197330 |
| 2026-04-28 | 07:50 ET | [10-Q](/filings/0001193125-26-183587.md) | Quarterly report, period 2026-03-31 | 0001193125-26-183587 |
| 2026-04-28 | 07:34 ET | [8-K](/filings/0001193125-26-183563.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-183563 |
| 2026-04-21 | 16:49 ET | [8-K](/filings/0001193125-26-167070.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-167070 |
| 2026-04-17 | 16:57 ET | [SCHEDULE 13D/A](/filings/0001346824-26-000110.md) | Ownership report, active investor, amended | 0001346824-26-000110 |
| 2026-04-15 | 16:08 ET | [8-K](/filings/0001193125-26-157003.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-157003 |
| 2026-03-30 | 20:32 ET | [SCHEDULE 13D/A](/filings/0001346824-26-000086.md) | Ownership report, active investor, amended | 0001346824-26-000086 |
| 2026-03-26 | 07:41 ET | [8-K](/filings/0001193125-26-125092.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-125092 |
| 2026-02-26 | 07:50 ET | [10-K](/filings/0001193125-26-073472.md) | Annual report, period 2025-12-31 | 0001193125-26-073472 |
| 2026-02-26 | 07:37 ET | [8-K](/filings/0001193125-26-073437.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-073437 |
| 2026-02-02 | 07:41 ET | [8-K](/filings/0001193125-26-032698.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-032698 |
| 2026-01-12 | 07:35 ET | [8-K](/filings/0001193125-26-009784.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-009784 |
| 2025-12-15 | 17:04 ET | [SCHEDULE 13D/A](/filings/0001346824-25-000072.md) | Ownership report, active investor, amended | 0001346824-25-000072 |
| 2025-12-11 | 21:47 ET | [8-K](/filings/0001193125-25-314746.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-314746 |
| 2025-12-08 | 07:37 ET | [8-K](/filings/0001193125-25-310595.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-310595 |
| 2025-11-17 | 07:30 ET | [8-K](/filings/0001193125-25-283929.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-283929 |
| 2025-11-13 | 20:47 ET | [SCHEDULE 13D/A](/filings/0001346824-25-000055.md) | Ownership report, active investor, amended | 0001346824-25-000055 |
| 2025-11-10 | 07:46 ET | [10-Q](/filings/0001193125-25-273288.md) | Quarterly report, period 2025-09-30 | 0001193125-25-273288 |
| 2025-11-10 | 07:35 ET | [8-K](/filings/0001193125-25-273278.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-273278 |
| 2025-10-30 | 06:04 ET | [8-K/A](/filings/0001193125-25-257298.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-257298 |
| 2025-10-29 | 17:22 ET | [8-K](/filings/0001193125-25-256682.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-256682 |
| 2025-09-24 | 08:30 ET | [8-K](/filings/0001193125-25-214176.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-214176 |
| 2025-09-03 | 07:40 ET | [8-K](/filings/0001193125-25-194511.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-194511 |
| 2025-08-11 | 17:18 ET | [8-K](/filings/0001193125-25-178083.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-178083 |
| 2025-08-05 | 08:00 ET | [8-K](/filings/0001193125-25-173053.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-173053 |
| 2025-07-30 | 07:45 ET | [10-Q](/filings/0000950170-25-099884.md) | Quarterly report, period 2025-06-30 | 0000950170-25-099884 |
| 2025-07-30 | 07:35 ET | [8-K](/filings/0001193125-25-168644.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-168644 |
| 2025-06-23 | 16:31 ET | [DEF 14A](/filings/0001193125-25-144678.md) | Proxy statement, period 2025-08-05 | 0001193125-25-144678 |
| 2025-05-08 | 07:45 ET | [10-Q](/filings/0000950170-25-066404.md) | Quarterly report, period 2025-03-31 | 0000950170-25-066404 |
| 2025-05-08 | 07:36 ET | [8-K](/filings/0001193125-25-115489.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-115489 |
| 2025-04-29 | 17:00 ET | [10-K/A](/filings/0000950170-25-060301.md) | Annual report, amended, period 2024-12-31 | 0000950170-25-060301 |
| 2025-03-26 | 07:38 ET | [8-K](/filings/0001193125-25-063184.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-063184 |
| 2025-03-04 | 07:59 ET | [10-K](/filings/0000950170-25-031322.md) | Annual report, period 2024-12-31 | 0000950170-25-031322 |
| 2025-03-04 | 07:51 ET | [8-K](/filings/0001193125-25-044876.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-044876 |
| 2025-01-13 | 14:00 ET | [8-K](/filings/0001193125-25-005233.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-005233 |
| 2024-11-20 | 06:05 ET | [8-K](/filings/0001193125-24-262067.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-262067 |
| 2024-11-12 | 07:40 ET | [10-Q](/filings/0000950170-24-124595.md) | Quarterly report, period 2024-09-30 | 0000950170-24-124595 |
| 2024-11-12 | 07:35 ET | [8-K](/filings/0001193125-24-255157.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-255157 |
| 2024-10-30 | 17:13 ET | [8-K](/filings/0001193125-24-247660.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-247660 |
| 2024-10-16 | 08:34 ET | [8-K](/filings/0001193125-24-237869.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-237869 |
| 2024-10-15 | 17:15 ET | [8-K](/filings/0001193125-24-237665.md) | 7.01 Regulation FD disclosure; 8.01 Other events | 0001193125-24-237665 |

Page 1 of 6. [Older](/companies/wve/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 16:33 ET. No prices; not investment advice.